Replies to post #391199 on Innovation Pharmaceuticals Inc (IPIX)

[Blues44]

OK, so the drug didn't produce the same result as it had in earlier tests. Are you implying that the possibility of B failing is preventing a big pharma from purchasing B? And if so, don't all pharma's take that risk when they are developing their drug candidates? Especially since B has supposed to have been tested and retested a number of times to where some are saying it will be the new SOC. Is that what you are saying?

[steelyeye]

Continued mutations creating new variants. BP will need to look at other treatment options, and soon!

Vaccines cannot keep up with mutations. Big possibilities ahead for small molecule compounds like Brilacidin.

https://www.marketwatch.com/story/new-omicron-variant-worries-experts-as-it-spreads-in-india-and-moderna-says-new-booster-offers-better-protection-against-ba-4-and-ba-5-11657549051?mod=mw_more_headlines